Skip to main content
SpringerLink
Log in

Treatment of Anxiety During Pregnancy

Effects of Psychotropic Drug Treatment on the Developing Fetus

  • Review Article
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

Pregnancy is a time of great emotional change for a woman, producing increased stress and anxiety. Medication may be required for the treatment of anxiety disorders at this time. Given the fact that psychotropic drugs readily cross the placenta and could have important implications for the developing fetus, it is necessary to balance the possible effects of medication against the potential effects to both the mother and fetus if the anxiety disorder is left untreated.

Despite the widespread use of psychotropic drugs such as benzodiazepines and antidepressants during pregnancy, there is a paucity of information regarding the effect of such exposure on the developing fetus.

From a review of the literature it is clear that the issue of safety of psychotropic drugs during pregnancy is far from resolved. While some of the findings from animal studies are alarming, these studies cannot be directly extrapolated to humans. In addition, varying sample sizes and multiple drug exposures further complicate interpretation of human studies.

Nonpharmacological treatments such as cognitive behavioural therapy should be employed whenever possible for the treatment of anxiety disorders during pregnancy. However, if medication is required pregnant women should be prescribed the lowest dosage for the minimum amount of time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Shear MK, Mammen O. Anxiety disorders in pregnant and post-partum women. Psychopharmacol Bull 1995; 31(4): 693–703

    PubMed  CAS  Google Scholar 

  2. Frailberg S, Adelson E, Shaoiro V. Ghosts in the nursery. J Am Acad Child Psychiatry 1975; 14: 387–421

    Google Scholar 

  3. Shear MK, Cooper AM, Klerman GL, et al. A psychodynamic model of panic disorder. Am JPsychiatry 1993; 150(6): 859–66

    CAS  Google Scholar 

  4. Sholomskas DE, Wickamaratne PJ, Dogolo L, et al. Postpartum onset of panic disorder — a coincidental event. J Clin Psychiatry 1993; 54(12): 476–80

    PubMed  CAS  Google Scholar 

  5. Cohen LS, Sichel DA, Dimmock JA, et al. Impact of pregnancy on panic disorder: a case series. J Clin Psychiatry 1994; 55(7): 293–4

    Google Scholar 

  6. Northcott CJ, Stein MB. Panic disorders in pregnancy. J Clin Psychiatry 1994; 55(12): 539–42

    PubMed  CAS  Google Scholar 

  7. George DT, Ladenheim JA, Nutt DJ. Effect of pregnancy on panic attacks. Am J Psychiatry 1987; 144(8): 1078–9

    PubMed  CAS  Google Scholar 

  8. Curran S, Nelson TE, Rodgers RJ. Resolution of panic disorder during pregnancy. Int J Psychol Med 1995; 12(3): 107–8

    Google Scholar 

  9. Wisner KL, Perel JM, Findling RL. Antidepressant treatment during breast feeding. Am J Psychiatry 1996; 153(9): 1132–7

    PubMed  CAS  Google Scholar 

  10. Cohen LS, Sichel DA, Faraone SV, et al. Course of panic disorder during pregnancy and the puerperium — a preliminary study. Biol Psychiatry 1996; 39(11): 950–4

    PubMed  CAS  Google Scholar 

  11. Pollitt J. Natural history of obsessional states. BMJ 1957; 194-7

  12. Ingram IM. Obsessional illness in mental hospital patients. J Ment Sci 1961; 107: 382–402

    PubMed  CAS  Google Scholar 

  13. Lo WH. A follow up of obsessional neurotics in Hong Kong Chinese. Br J Psychiatry 1967; 113: 823–32

    PubMed  CAS  Google Scholar 

  14. Iancu I, Lepkifker E, Dannon P, et al. Obsessive compulsive disorder limited to pregnancy. Psychother Psychosom 1995; 64(2): 109–12

    PubMed  CAS  Google Scholar 

  15. Brandt KR, MacKenzie TB. Obsessive compulsive disorder exacerbated during pregnancy: a case report. Int J Psychiatry Med 1987; 17(4): 361–6

    PubMed  CAS  Google Scholar 

  16. Williams KE, Koran LM. Obsessive compulsive disorder in pregnancy, the puerperium and the premenstrum. J Clin Psychiatry 1997; 58(7): 330–4

    PubMed  CAS  Google Scholar 

  17. Laux G. Therapy with bezodiazepines revised — a clinical review. Nervenarzt 1995; 66(5): 311–22

    PubMed  CAS  Google Scholar 

  18. Marchetti F, Romero M, Bonati M, et al. Use of psychotropic drugs during pregnancy, a report of the international co-operative drug use in pregnancy (DUP) study. Eur J Clin Pharmacol 1993 45: 495–501

    PubMed  CAS  Google Scholar 

  19. Burrows GD, Judd FK, Norman TR. Diagnosis and treatment of panic, anxiety and depression. CNS Drugs 1994; (2): 119–31

    Google Scholar 

  20. Murphy DL, Pato MT, Pigott TA. Obsessive-compulsive disorder: treatment with serotonin selective reuptake inhibitors, azaspirones and other agents. J Clin Psychiatry 1990; 10 Suppl. 3: 91S–100S

    CAS  Google Scholar 

  21. Stowe ZN, Nemeroff CB. Psychopharmacology during pregnancy and lactation. In: Schatzberg AF, Nemeroff CB, editors. Textbook of psychopharmacology. Washington (DC): American Psychiatric Press 1995: 823–37

    Google Scholar 

  22. Robinson L, Walker JR, Anderson D. Cognitive behavioural treatment of panic disorder during pregnancy and lactation. Can J Psychiatry 1992; 37(9): 623–6

    PubMed  CAS  Google Scholar 

  23. Kacew S. Fetal consequences and risks attributed to the use of prescribed and over the counter (OTC) preparations during pregnancy. Int J Clin Pharmacol Ther 1994; 32(7): 335–43

    PubMed  CAS  Google Scholar 

  24. Wadhwa PD, Sandman CA, Porto M, et al. The association between prenatal stress and infant birthweight and gestational age at birth: a prospective investigation. Am J Obstet Gynecol 1993; 169(4): 858–65

    PubMed  CAS  Google Scholar 

  25. Lou HC, Hansen D, Nordentoft M, et al. Prenatal stressors of human life affect fetal brain development. Dev Med Child Neurol 1994; 36(9): 826–32

    PubMed  CAS  Google Scholar 

  26. Sandman CA, Wadhwa PD, Dunkel-Schetter C, et al. Psycho-biological influences of stress and HPA regulation on the human fetus and infant birth outcomes. Ann N Y Acad Sci 1994; 31(739): 198–210

    Google Scholar 

  27. Orr ST, James SA, Miller CA, et al. Psychosocial stressors and low birthweight in an urban population. Am J Prev Med 1996; 12(6): 459–66

    PubMed  CAS  Google Scholar 

  28. Sandman CA, Wadhwa PD, Chicz-DeMet A, et al. Maternal stress, HPA activity, and fetal/infant outcome. Ann N Y Acad Sci 1997; 24(814): 266–75

    Google Scholar 

  29. Pagel MD, Smilkstein G, Regen H, et al. Psychosocial influences on newborn outcomes: a controlled prospective study. Soc Sci Med 1990; 30(5): 597–604

    PubMed  CAS  Google Scholar 

  30. Farber EA, Vaughn B, Egeland B. The relationship of prenatal maternal anxiety to infant behaviour and mother infant interaction during the first six months of life. Early Hum Dev 1981; 5(3): 267–77

    PubMed  CAS  Google Scholar 

  31. Selvaggi L, Diaferia A, Loizzi P, et al. Effect of maternal anxiety (unrest) on the health status of the fetus. Zentralbl Gynakol 1984; 106(23): 1528–35

    PubMed  CAS  Google Scholar 

  32. Perkin MR, Bland JM, Peacock JL, et al. The effect of anxiety and depression during pregnancy on obstetric complications. Br J Obstet Gynaecol 1993; 100(7): 629–34

    PubMed  CAS  Google Scholar 

  33. Jacobsen G, Schei B, Hoffman HJ. Psychosocial factors and small for gestational age infants among parous Scandinavian women. Acta Obstet Gynecol Scand 1997; 165 Suppl.: 14–28

    CAS  Google Scholar 

  34. Sokol L, Beck AT, Greenberg RL, et al. Cognitive therapy of panic disorder. A nonpharmacological alternative. J Nerv MentDis 1989; 177(12): 711–6

    CAS  Google Scholar 

  35. Alshuler LL, Conen L, Szuba MP, et al. Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines. Am J Psychiatry 1996; 153(5): 592–606

    Google Scholar 

  36. Owen G, Smith T, Agersborg H. Toxicity of some benzodiazep-ine compounds with CNS activity. Toxicol Appl Pharmacol 1970; 16: 556–70

    PubMed  CAS  Google Scholar 

  37. Beall JR. Study of the teratogenic potential of diazepam and SCH 12041. Can Med Assoc J 1972; 106: 1061

    PubMed  CAS  Google Scholar 

  38. Walker BE, Patterson A. Induction of cleft palate in mice by tranquillisers and barbiturates. Teratology 1974; 10(2): 159–63

    PubMed  CAS  Google Scholar 

  39. Brunard M. Effect of the meprobamate acepromethazine combination on pregnancy, fetal morphology and postnatal development. Boll Chim Farm 1975; 108: 560–75

    Google Scholar 

  40. Miller RP, Becker BA. Teratogenicity of oral diazepam and di-phenylhydantoin in mice. Toxicol Appl Pharmacol 1975; 32(1): 53–61

    PubMed  CAS  Google Scholar 

  41. Stenchever MA, Parks KJ. Some effects of diazepam on pregnancy in the Balb/C mouse. Am J Obstet Gynecol 1975; 121: 765–70

    PubMed  CAS  Google Scholar 

  42. Guerriero FJ, Fox KA. Benzodiazepines and development of Swiss-Webster mice. Pharmacol Res Commun 1977; 9: 187–96

    PubMed  CAS  Google Scholar 

  43. Tuchmann-Duplessis H. Influence des benzodiazepines sur le development prenatal [abstract]. International Symposium, Les Etats Anxieux: Aspects Biologiques et Clinique: 1977 Oct; Montpellier, France

  44. Ramamurthy SV, Chaudhry AP. Valium (diazepam) — its effects on hamster intrauterine fetal growth. J Dent Res 1979; 58: 2011

    PubMed  CAS  Google Scholar 

  45. Shah RM, Donaldson D, Burdett D. Teratogenic effects of diazepam in the hamster. Can J Physiol Pharmacol 1979; 57: 556–61

    PubMed  CAS  Google Scholar 

  46. Barlow SM, Knight AF, Sullivan FM. The role of endogenous maternal corticosterone. Teratology 1980; 21: 149–55

    PubMed  CAS  Google Scholar 

  47. Buttar HS. The effects of the combined administration of etha-nol and chlordiazepoxide on the prenatal and post natal development of rats. Neurobehav Toxicol 1980; 2: 270–325

    Google Scholar 

  48. Corwin H, DeMeyer W. Failure of clorazepate to cause malformations or fetal wastage in the rat. Arch Neurol 1980; 37: 347–9

    PubMed  CAS  Google Scholar 

  49. Gill TS, Guram MS, Geber WE Comparative study of the teratogenic effects of chlordiazepoxide and diazepam in the fetal hamster. Life Sci 1981; 29(21): 2141–7

    PubMed  CAS  Google Scholar 

  50. Alleva E, Laviola G, Tirelli E, et al. Short, medium and long term effects of prenatal oxazepam on neurobehavioural development of mice. Psychopharmacology 1985; 87: 434–41

    PubMed  CAS  Google Scholar 

  51. Cagiano R, De Salvia MA, Perischelle M, et al. Behavioural changes in the offspring of rats exposed to diazepam during gestation. Eur J Pharmacol 1990; 177(1-2): 67–74

    PubMed  CAS  Google Scholar 

  52. Vorster W, Liebenberg SW, Lizamore DJ. The effect of diazepam on the development of gallus embryos. S Afr JSci 1995; 91(10): 538–41

    CAS  Google Scholar 

  53. Jackson V, DeMeyer W, Hingtgen J. Delayed maze learning in rats after prenatal exposure to clorazepate. Arch Neurol 1980; 37(6): 350–1

    Google Scholar 

  54. Livezey GT, Radulovacki M, Isaac L, et al. Prenatal exposure to diazepam: late postnatal teratogenic effect. Neurobehav Toxicol Teratol 1986; 8: 433–40

    PubMed  CAS  Google Scholar 

  55. Jaiswal AK, Bhattacharya SK. Effects of gestational undernu-trition, stress and diazepam treatment on spatial discrimination learning and retention in young rats. Indian J Exp Biol 1993; 31(4): 353–9

    PubMed  CAS  Google Scholar 

  56. Ljubimov BI, Smolnikova NM, Strekalova SN. Effect of diazepam on the development of the offspring. Bull Exp Biol Med 1974; 78: 1156–8

    Google Scholar 

  57. Hoffeld DR, McNew J, Webster RL. Effect of tranquillising drugs during pregnancy on activity of offspring. Nature 1968; 218: 357–8

    PubMed  CAS  Google Scholar 

  58. Kellogg C, Tervo D, Ison J, et al. Prenatal exposure to diazepam alters behavioural development in rats. Science 1980; 207: 205–7

    PubMed  CAS  Google Scholar 

  59. Latinien K, MacDonald E, Saano V. Effects of diazepam, tofizopam or phenytoin during foetal development on subsequent behaviour and benzodiazepine receptor characteristics in rats. Arch Toxicol 1986; 9 Suppl.: 51–4

    Google Scholar 

  60. Gruen RJ, Deutch AY, Roth RH. Perinatal diazepam exposure: alterations in exploratory behaviour and mesolimbic dopamine turnover. Pharmacol Biochem Behav 1990; 36(1): 169–75

    PubMed  CAS  Google Scholar 

  61. Pankaj V, Brain PF. Effect of prenatal exposure to benzodiazepine related drugs on early development and adult social behaviour in Swiss mice — I: agonists. Gen Pharmacol 1991; 22(1): 33–41

    PubMed  CAS  Google Scholar 

  62. Singh Y, Jaiswal AK, Singh M, et al. Behavioural effects of prenatal diazepam administration on anxiety patterns in rats. Ind J Exp Biol 1996; 34(11): 1095–9

    CAS  Google Scholar 

  63. Pankaj V, Brain PF. Effect of prenatal exposure to benzodiazepine related drugs on early development and adult social behaviour in Swiss mice — III: inverse agonists. Gen Pharmacol 1991; 22(10): 53–60

    PubMed  CAS  Google Scholar 

  64. Pankaj V, Brain PF. Effects of prenatal exposure to benzodiazepine-related drugs on early development and adult social behaviour in Swiss mice-II antagonists. Gen Pharmacol 1991: 22(1): 43–51

    PubMed  CAS  Google Scholar 

  65. Kurshingal H, Palanza P, Brain PF. Effects of exposure of pregnant mice to chlordiazepoxide (CDP) on the development and ultrasound production of their offspring. Gen Pharmacol 1992; 23(1): 49–53

    Google Scholar 

  66. Saxen I, Saxen L. Association between maternal intake of diazepam and oral clefts. Lancet 1975; 13: 498

    Google Scholar 

  67. Safra MJ, Oakley GP. Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet 1975; II: 478–80

    Google Scholar 

  68. Aarskog D. Association between maternal intake of diazepam and oral clefts. Lancet 1975; 8: 921

    Google Scholar 

  69. Crombie DL, Pinsent RJ, Fleming DJ, et al. Fetal effects of tranquillisers in pregnancy. N Engl J Med 1975; 293: 198–9

    PubMed  CAS  Google Scholar 

  70. Patel DA, Patel AR. Letter Chlorazepate and congenital malformations [letter]. JAMA 1980; 244: 135–6

    PubMed  CAS  Google Scholar 

  71. Laegreid L, Olegard R, Wahlstrom J, et al. Abnormalities in children exposed to benzodiazepines in utero. Lancet 1987; 10: 108–9

    Google Scholar 

  72. Milkovich L, Van den Berg BJ. Effects of prenatal meprobamate and chlordiazepoxide hydrochloride on human embryonic and fetal development. N Engl J Med 1974; 291: 1268–71

    PubMed  CAS  Google Scholar 

  73. Hartz S, Heinonen OP, Shapiro S, et al. Antenatal exposure to meprobamate and chlordiazepoxide in relation to malformations, mental development and childhood mortality. N Engl J Med 1975; 292: 726–8

    PubMed  CAS  Google Scholar 

  74. DeLaney AG. Anaesthesia in the pregnant women. Clin Obstet Gynecol 1983; 26: 795–800

    PubMed  CAS  Google Scholar 

  75. Rosenberg L, Mitchell AA, Parsells JL, et al. Lack of relation of oral clefts to diazepam use during pregnancy. N Engl J Med 1983; 24: 1282–5

    Google Scholar 

  76. Entman SS, Vaughan WK. Lack of relation of oral clefts to diazepam use in pregnancy. New Engl J Med 1984; 310: 1121–2

    PubMed  CAS  Google Scholar 

  77. McElhatton PR. The effect of benzodiazepine use during pregnancy and lactation. Reprod Toxicol 1994; 8(6): 461–75

    PubMed  CAS  Google Scholar 

  78. Shiono PH, Mills JL. Oral clefts and diazepam use during pregnancy [letter]. New Engl J Med 1984; 311: 919–20

    PubMed  CAS  Google Scholar 

  79. Stika L, Elisova K, Honzakova L, et al. Effects of drug administration in pregnancy on children’s school behaviour. Pharm Weekbl Sci 1990; 12(6): 252–5

    PubMed  CAS  Google Scholar 

  80. Viggedal G, Hagberg BS, Laegreid L, et al. Mental development in late infancy after prenatal exposure to benzodiazepines — a prospective study. J Child Psychol Psychiatry 1993; 34(3): 295–305

    PubMed  CAS  Google Scholar 

  81. Vorhees CV, Acuff Smith KD, Schilling MA, et al. A developmental neurotoxicity evaluation of the effects of prenatal exposure to fluoxetine in rats. Fundam Appl Toxicol 1994; 23(2): 194–205

    PubMed  CAS  Google Scholar 

  82. Simpkins JW, Field FP, Torosian G, et al. Effects of prenatal exposure to tricyclic antidepressants on adrenergic responses in progeny. Dev Pharmacol Ther 1985; 8(1): 17–33

    PubMed  CAS  Google Scholar 

  83. Robson JM, Sullivan FM. The production of foetal abnormalities in rabbits by imipramine. Lancet 1963; 1: 638–9

    PubMed  CAS  Google Scholar 

  84. Oberholzer RJH. Contribution a 1’etude d’une action teratogene eventuelle de 1’imipramine. Med Hyg 1964; 22: 557

    Google Scholar 

  85. Jelinek V, Zikund E, Reichlova R. L’influence de quelques médicaments psychotropes sur le développement du foetus chez le rat. Thérapie 1967; 22: 1429–33

    PubMed  CAS  Google Scholar 

  86. Aeppli L. Teratogenic studies with imipramine in rats and rabbits: planning and interpretation of teratologic studies under consideration of the biochemistry and toxicology of test substance. Arzneimittel Forschung 1969; 19(10): 1617–40

    PubMed  CAS  Google Scholar 

  87. Guram MS, Gill TS, Geber WE Comparative teratogenicity of chlordiazepoxide, amitriptyline and a combination of the two in the fetal hamster. Neurotoxicity 1982; 3(3): 83–90

    CAS  Google Scholar 

  88. Stanford MS, Patton JH. In utero exposure to fluoxetine HCL increases hematoma frequency at birth. Pharmacol Biochem Behav 1993; 45(4): 959–62

    PubMed  CAS  Google Scholar 

  89. Harper KH, Palmer AK, Davies RE. Effect of imipramine upon the pregnancy of laboratory animals. Arzneimittel Forschung 1965; 15: 1218

    CAS  Google Scholar 

  90. Beyer BK, Guram MS, Geber WF. Incidence and potentiation of external and internal fetal abnormalities resulting from chlordiazepoxide and amitriptyline alone and in combination. Teratology 1984; 30(1): 39–45

    PubMed  CAS  Google Scholar 

  91. Hendrickx A. Teratogenic evaluation of imipramine hydrochloride in bonnet (Macca radiata), and rhesus monkeys (Maccamulatta). Teratology 1975; 11: 219–22

    PubMed  CAS  Google Scholar 

  92. Coyle IR, Singer G. The interaction of post-weaning housing conditions and prenatal drug effects on behaviour. Psy-chopharmacologia 1975; 41(3): 237–44

    CAS  Google Scholar 

  93. Coyle IR, Singer G. The interactive effects of prenatal imipra-mine exposure and postnatal rearing conditions on behaviour and histology. Psychopharmacologia 1975; 44(3): 253–6

    PubMed  CAS  Google Scholar 

  94. File SE, Tucker JC. Prenatal treatment with clomipramine has an anxiolytic profile in the adolescent rat. Physiol Behav 1983; 31(1): 57–61

    PubMed  CAS  Google Scholar 

  95. Roderiquez-Echandia E, Broitman S. Effect of prenatal and postnatal exposure to therapeutic doses of chlorimipramine on emotionality in the rat. Psychopharmacology 1983; 79: 236–41

    Google Scholar 

  96. Drago F, Continella G, Alloro MC, et al. Behavioural effects of perinatal administration of antidepressant drugs in the rat. Neurobehav Toxicol Teratol 1985; 7(5): 493–7

    PubMed  CAS  Google Scholar 

  97. Mirmiran M, Brenner E, Van Der Gugten J, et al. Neurochemi-cal and electrophysiological disturbances mediate developmental behavioural alterations produced by medicines. Neurobehav Toxicol Teratol 1985; 7(6): 677–83

    PubMed  CAS  Google Scholar 

  98. Coyle IR. Changes in developing behaviour following prenatal administration of imipramine. Pharmacol Biochem Behav 1975; 3: 799–807

    PubMed  CAS  Google Scholar 

  99. Banister P. Dafoe C, Smith E, et al. Possible teratogenicity of tricyclic antidepressants [letter]. Lancet 1972; I: 838–9

    Google Scholar 

  100. Crombie DL, Pinsent RJ, Fleming D. Imipramine in pregnancy [letter]. BMJ 1972; 1: 745

    PubMed  CAS  Google Scholar 

  101. Freeman R. Limb deformities: possible association with drugs [letter]. Med J Aust 1972; 1: 606–7

    PubMed  CAS  Google Scholar 

  102. Kuensberg EV, Knox JD. Imipramine in pregnancy [letter]. BMJ 1972; 2: 292

    Google Scholar 

  103. McBride WG. Limb deformities associated with iminodibenzyl hydrochloride [letter]. Med J Aust 1972; 1: 492

    PubMed  CAS  Google Scholar 

  104. Rachelefsky GS, Flynt JW, Ebbin AJ, et al. Possible teratogenicity of tricyclic antidepressants [letter]. Lancet 1972; I: 838–9

    Google Scholar 

  105. Idanpaan-Heikkila J, Saxen L. Possible teratogenicity of imip-ramine/chloropyramine. Lancet 1973; II: 282–4

    Google Scholar 

  106. Golden S, Perman K. Bilateral clinical anopthalmia: Drugs as potential factors. South Med J 1980; 73: 1404–7

    PubMed  CAS  Google Scholar 

  107. Misri S, Sivertz K. Tricyclic drugs in pregnancy and lactation: a preliminary report. Int J Psychiatry Med 1991; 21(2): 157–71

    PubMed  CAS  Google Scholar 

  108. Pastuszak A, Schick-Boschetto B, Zuber C, et al. Pregnancy outcome following first trimester exposure to fluoxetine. JAMA 1993; 269(17): 2246–8

    PubMed  CAS  Google Scholar 

  109. Chambers CD, Johnson KA, Dick LM, et al. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996; 335(14): 1010–5

    PubMed  CAS  Google Scholar 

  110. Kulin NA, Pastuszak A, Sage SR, et al. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors — a prospective controlled multicenter study. JAMA 1998; 279(8): 609–10

    PubMed  CAS  Google Scholar 

  111. Abramovici A, Abramovici I, Kalman G, et al. Teratogenic effect of chlorimipramine in young human embryo [abstract]. Teratology 1981; 24: 42A

    Google Scholar 

  112. Nulman I, Rovet J, Stewart DE, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997; 336(4): 258–62

    PubMed  CAS  Google Scholar 

  113. Wilson JG. Present status of drugs as teratogens in man. Teratology 1972; 7: 3–16

    Google Scholar 

  114. Buist A, Janson H. Effect of exposure to dothiepin and northiaden in breast milk on child development. Br J Psychiatry 1995; 167(3): 370–3

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Melbourne, Heidelberg, Victoria, Australia

    Caroline McGrath & Trevor R. Norman

  2. Department of Psychiatry, University of Melbourne, Australia

    Anne Buist

Authors
  1. Caroline McGrath
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne Buist
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Trevor R. Norman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Caroline McGrath.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McGrath, C., Buist, A. & Norman, T.R. Treatment of Anxiety During Pregnancy. Drug-Safety 20, 171–186 (1999). https://doi.org/10.2165/00002018-199920020-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199920020-00006

Keywords

Search

Navigation